Aprea Therapeutics
APRE
APRE
22 hedge funds and large institutions have $1.45M invested in Aprea Therapeutics in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% less capital invested
Capital invested by funds: $2.39M → $1.45M (-$941K)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$418K | |
| 2 | +$148K | |
| 3 | +$62.7K | |
| 4 |
Jane Street
New York
|
+$57.2K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$29.8K |
Top Sellers
| 1 | -$207K | |
| 2 | -$202K | |
| 3 | -$166K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$123K |
| 5 |
HF
HRT Financial
New York
|
-$18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LCM
26
Landscape Capital Management
Englewood,
New Jersey
| – |
|
|||
|
MLA
27
MB, Levis & Associates
Center Valley,
Pennsylvania
| – |
|
|||
28
Citigroup
New York
| – |
|